Lynda Charters

Christina Y. Weng, MD, MBA, Baylor College of Medicine, Houston, discussed therapies for macular degeneration.

Vision loss was prevented in a mouse model of Fuchs endothelial corneal dystrophy.

Improved knowledge of the effects of mutations in the EYS gene may help inform new treatments.

A single-dose gene therapy for uveitis could fill an important treatment gap for patients.

A new animal model will facilitate the study and development of gene therapies in retinal diseases.

Targeted CRISPR therapy has potential in treating inherited retinal diseases.

Clinical trials for both AGTC-401 and AGTC-402 show promising results.

Short-term morphological rescue was seen after voretigene neparvovec-rzyl treatment.

The OPTIC phase 1 study showed that the treatment was associated with a significant reduction in treatment burden after 1 injection.

Optical coherence tomography characteristics may be predictive of the efficacy of intravitreal injection of allogeneic human retinal progenitor cells, according to research presented at ARVO 2021.